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We have studied the membrane insertion of ProW, an
Escherichia coli inner membrane protein with seven
transmembrane segments and a large periplasmic N-
terminal tail, into endoplasmic reticulum (ER)-derived
dog pancreas microsomes. Strikingly, significant levels
of N-tail translocation is seen only when a minimum of
four of the transmembrane segments are present; for
constructs with fewer transmembrane segments, the N-
tail remains mostly nontranslocated and the majority of
the molecules adopt an “inverted” topology where nor-
mally nontranslocated parts are translocated and vice
versa. N-tail translocation can also be promoted by
shortening of the N-tail and by the addition of positively
charged residues immediately downstream of the first
trasnmembrane segment. We conclude that as many as
four consecutive transmembrane segments may be col-
lectively involved in determining membrane protein to-
pology in the ER and that the effects of downstream
sequence determinants may vary depending on the size
and charge of the N-tail. We also provide evidence to
suggest that the ProW N-tail is translocated across the
ER membrane in a C-to-N-terminal direction.
The structure and function of integral membrane proteins
are in part determined by their topology, i.e. the orientation
(Ncyt or Nexo) of each transmembrane segment (TM)
1 relative to
the membrane. Two general mechanisms for the membrane
assembly of a polytopic membrane protein have been proposed.
In the first, the overall topology is assumed to be determined by
the most N-terminal TM, with downstream TMs serving alter-
nately as stop transfer and signal anchor sequences (1). The
second model suggests that topogenic information is spread
throughout the protein and that downstream TMs may affect
the orientation of upstream ones (2–4).
One aspect of membrane protein assembly that is not fully
understood is the translocation of N-terminal tails (N-tails)
across the membrane (5). N-tail translocation is presumably
initiated by a hydrophobic “reverse signal-anchor” sequence
that also becomes the first TM segment (6–10). In eukaryotic
cells, N-tail translocation has been shown to proceed by the
normal signal recognition particle-Sec61 pathway (11) and to
require an unfolded N-terminal domain (12). In contrast, N-tail
translocation in Escherichia coli appears to be possible both by
a SecA-dependent (10) and by a Sec-independent mechanism
(6–8, 13), depending on the protein. In both prokaryotic and
eukaryotic cells, it seems that the presence of too many posi-
tively charged amino acids can prevent N-tail translocation,
whereas negatively charged residues may facilitate transloca-
tion (6, 7, 14–17).
The 100-residue-long periplasmic N-terminal domain of the
E. coli inner membrane protein ProW (6, 18) is one of the
longest known N-tails. Earlier studies in E. coli have shown
that the ProW N-tail can be efficiently translocated across the
inner membrane (6, 7). We have now expressed ProW in vitro in
the presence of ER-derived dog pancreas microsomes and have
studied N-tail translocation in the full-length protein as well as
in fusion constructs lacking one or more TM segments and with
N-tails of different lengths. Strikingly, and in contrast to pre-
vious findings in E. coli, we find that a minimum of four TM
segments must be present to reach appreciable levels of N-tail
translocation; constructs with up to three TM segments mainly
adopt an “inverted” topology with the N-tail in the cytoplasm.
Shortening of the N-tail increases translocation efficiency and
reduces the number of TMs that need to be present for N-tail
translocation to occur.
The full-length ProW N-tail is efficiently translocated across
the ER membrane when fused to the N terminus of another E.
coli inner membrane protein, leader peptidase (Lep). Studies of
the kinetics of glycosylation of Asn-Xaa-Thr acceptor sites lo-
cated either early or late in the N-tail in this construct strongly
suggest that N-tail translocation proceeds in a C-to-N-terminal
direction.
These observations show that the whole TM1-TM4 region of
ProW can influence N-tail translocation across the ER mem-
brane. Thus, distant downstream sequence determinants can
affect the insertion of the most N-terminal parts of a polytopic
membrane protein into the ER membrane.
MATERIALS AND METHODS
Enzymes and Chemicals—Unless otherwise stated, all enzymes as
well as plasmid pGEM1, RiboMAX SP6 RNA polymerase system, and
rabbit reticulocyte lysate were from Promega (Madison, WI) or New
England Biolabs (Boston, MA). T7 DNA polymerase, Taq polymerase,
[35S]Met and 14C-methylated marker proteins, ribonucleotides, deoxyri-
bonucleotides, dideoxyribonucleotides, and the cap analog
m7G(59)ppp(59)G were from Amersham Pharmacia Biotech. Aurintri-
carboxylic acid was from Sigma. Qiagen PCR purification kit and Qia-
gen RNeasy RNA clean up were from Qiagen (Hilden, Germany). Oli-
gonucleotides were from Kebo Lab and Cybergene (Stockholm,
Sweden).
DNA Techniques—Site-specific mutagenesis was performed accord-
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ing to the method of Kunkel (19, 20) or by PCR. All mutants were
confirmed by sequencing of plasmid DNA. PCR was used to amplify
fragments from pING1 (21) and pGEM1 plasmids containing the de-
sired DNA constructs. The amplified DNA products were purified using
Qiagen PCR purification kit as described in the manufacturer’s proto-
col. All cloning steps were done according to standard procedures.
Construction of Full-length and Truncated ProW Glycosylation Mu-
tants—The gene coding for E. coli ProW was amplified by PCR from
genomic DNA using 59- and 39-specific oligonucleotides containing N- or
C-terminal glycosylation sites (see below) and suitable restriction sites
for cloning into pGEM1. The full-length ProW construct containing an
N-terminal glycosylation site was engineered using a 59-specific oligo-
nucleotide, which introduced a mutation encoding the N-glycosylation
site Asn5-Asn6-Thr7 near the N terminus of ProW, a Kozak consensus
sequence (22) for enhanced translation, and a XbaI site for cloning
(modified nucleotides underlined): . . . ACCTCTAGAGCCACCATG-
GCTGATCAAAATAATACGTGGGATACCACGCCAGCG. . . . The re-
verse oligonucleotide encoded the 39 end of ProW, a stop codon, and a
SmaI site for cloning. Truncated ProW molecules were made in the
same way, but with the reverse 39 oligonucleotide (including stop
codons) hybridizing to the relevant internal portions of the proW gene.
The C-terminal C* reporter domain was introduced by a two-step
PCR amplification. In the first step a common 59-specific primer and
individual 39-primers specific for the full-length gene and the various
truncations, were used. The common 59-specific primer was identical to
the one described above except that it lacked the glycosylation acceptor
site. The individual 39-oligonucleotides introduced a C-terminal Asn-
Leu-Thr glycosylation site located at least 16 amino acid residues down-
stream of the nearest transmembrane domain. To increase the glyco-
sylation efficiency of the C* reporter, a second PCR amplification was
done using the same common 59-specific primer described above and a
common 39-specific primer introducing a C-terminal extension of 18
amino acid residues downstream of the Asn-Leu-Thr site followed by a
SmaI restriction site for cloning into pGEM1. The encoded sequence of
the spacer behind the glycosylation site was SGKENGIRLSER-
KETLGD. The PCR products were cloned into XbaI-SmaI-restricted
pGEM1 plasmids.
Construction of ProW/P2 and ProW/P29 Fusions—The construction
of ProW/P2 fusions in pING1 containing up to three transmembrane
segments was described previously (23). Cloning into pGEM1 was done
using ProW/P2 XbaI-SmaI fragments that were amplified from the
corresponding pING1 constructs using a universal 59-specific primer
containing an XbaI site and a Kozak consensus sequence (see above)
and individual 39-specific primers containing a SmaI site. For the
construction of ProW/P2 fusions containing four to seven transmem-
brane segments, the appropriate fragments amplified by PCR from the
genomic copy of ProW were cloned into a XbaI-KpnI-restricted pGEM1
ProW(TM1–3)/P2 plasmid. The ProW/P29 fusions were constructed in a
similar way, except that the 39 primer introduced a stop codon in
position 216 in Lep (this removes the naturally occurring glycosylation
site at Asn214), together with a SacI restriction site. Site-specific mu-
tagenesis was used to introduce three Arg residues between positions
119 and 120 in the ProW TM1–2 loop. The three Arg mutants were
cloned into pGEM1 as an XbaI-SmaI fragment.
Shortening of the N-tail in ProW/P2 and ProW/P29
Fusions—mRNAs encoding constructs with shortened ProW N-tails
were prepared using PCR to amplify fragments from the relevant
pGEM1 plasmids.2 The 59 primers all had the common sequence 59-G-
ATTTAGGTGACACTATAGAGGAAACAGGACCATGGCCAATTCCA-
CC. . . . .-39 and contained the SP6 transcriptional promoter, a ribo-
some-binding site, an initiator codon, and a Asn-Ser-Thr glycosylation
site (underlined). The unique sequence at the 39 end was designed to
hybridize at the position of the first residue after the intended deletion
in the N-tail. Constructs with ProW residues 1–30, 1–50, and 1–70
deleted were made (note that the PCR primer adds 5 residues to the N
terminus of the deletion constructs). The 39 primers were chosen to have
a stop codon in position 216 or 324 in Lep as detailed above.
Construction of ProW N-tail-Lep Fusions—Nt/Lep fusions were con-
structed by PCR amplification of relevant fragments of the proW and
lep genes to create in-frame fusions with Lep residues 1–323 or 1–215.
The fusion joint in the Nt/Lep fusion proteins was -QQ99 TRM1A-
(numbers refer to the wild-type ProW and Lep sequences). The ProW
N-tail was amplified using a 59 primer situated 210 bases upstream of
the translation start and a 39 primer at position 99 in ProW containing
a SpeI site. The 59 primer for the amplification of Lep contained a XbaI
site and the 39 primer had a stop codon in positions 216 or 324. The
cleaved PCR fragments were purified on agarose gel and were ligated
directly in the gel. Templates for in vitro transcription of mRNA were
prepared using PCR to amplify the ligated fragments using the same
SP6 promoter-containing 59 primer and the same 39 primers with stop
codons at either position 216 or 324 in Lep as above. In construct
*Nt(Asn80)/Lep-P29, the glycosylation acceptor site in the ProW N-tail
had the sequence Asn80-Ser-Thr.
In Vitro Transcription—Templates for in vitro transcription were
prepared as described in Ref. 24 or by PCR amplification with the
pGEM1 constructs as template. The 59 primer was the same in all cases
and had the sequence 59-TTCGTCCAACCAAACCGACTC-39 (except
when the SP6 promoter-containing primers were used; see above). This
primer is situated 210 bases upstream of the translational start, and
the amplified fragments thus contained the SP6 transcriptional pro-
moter from pGEM1. The 39 primers contained stop codons in the ap-
propriate positions. Amplified PCR fragments were transcribed from
the SP6 promoter using the Large Scale RNA Synthesis kit with the
RiboMAX SP6 RNA polymerase system. Transcriptions were carried
out at 30 °C for 12 h. The mRNAs were purified using Qiagen RNeasy
clean up kit and verified on a 1% agarose gel.
In Vitro Translation—Translation in reticulocyte lysate in the pres-
ence of dog pancreas microsomes was performed as described in Ref. 24.
Sodium carbonate extraction of microsomes was carried out as de-
scribed in Ref. 25. Proteins were analyzed by SDS-polyacrylamide gel
electrophoresis, and gels were quantitated on a Fuji BAS1000 phospho-
imager using the MacBAS 2.31 software. The extent of glycosylation of
a given mutant was calculated as the quotient between the intensity of
the glycosylated band divided by the summed intensities of the glyco-
sylated and nonglycosylated bands. In general, the glycosylation effi-
ciency varied by no more than 6 5% between repeat experiments.
Kinetics of glycosylation was measured as described in Ref. 26, and the
results were quantitated by phosphoimager analysis.
RESULTS
To study N-tail translocation in the ProW protein in a mi-
crosome-supplemented in vitro translation system, we engi-
neered series of ProW fusion proteins and truncated ProW
variants containing unique N- or C-terminal N-glycosylation
acceptor Asn-Xaa-Thr sites. In most constructs, the N-terminal
glycosylation site was placed at residues 5–7 in the ProW N-tail
by mutating these residues to Asn-Asn-Thr. As C-terminal
reporters we used both the P2-domain (residues 81–323) from
the E. coli inner membrane protein Lep and a short C-terminal
tag (C*) including an Asn-Leu-Thr glycosylation acceptor site
followed by an 18-residue-long tail (see “Materials and Meth-
ods”). The P2 reporter has a naturally occurring glycosylation
site (Asn214-Glu-Thr) and is well suited for topological map-
pings based on N-linked glycosylation (27, 28). A truncated
version of the P2 domain, P29 (residues 81–215), lacking the
glycosylation site was also used. All constructs were expressed
in vitro in the absence or presence of dog pancreas rough
microsomes. Because N-linked glycosylation occurs only in the
lumen of the microsomes, the localization of the introduced
acceptor sites can be determined by assaying their glycosyla-
tion status. Addition of a single N-linked oligosaccharide to the
nascent chain leads to an increase in molecular mass of about
2 kDa that is easily detectable by SDS-polyacrylamide gel
electrophoresis.
Topology of Full-length ProW in Microsomes—The topology
of ProW in the inner membrane of E. coli has previously been
determined by PhoA/LacZ fusion analysis and protease map-
ping (6, 18). As shown in Fig. 1, the protein has seven TM
segments, and the long N-tail is located in the periplasm. The
topology of full-length ProW in microsomes was probed by (i)
introducing a glycosylation acceptor site in positions 5–7 in the
N-tail, (ii) constructing a full-length ProW/P2* fusion, and (iii)
adding a short C-terminal extension (C*) containing a glycosy-
lation acceptor site to the full-length protein. In what follows,
an asterisk always indicates the presence of an Asn-Xaa-Thr
glycosylation acceptor site in the relevant domain.
As shown in Fig. 2, ;30% of the molecules with the N-2 W. Mothes, personal communication.
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terminal acceptor site were glycosylated when expressed in
vitro in the presence of microsomes, whereas essentially no
glycosylation was seen for the two C-terminal reporters. Be-
cause the maximal glycosylation efficiency routinely obtained
in our in vitro system is ;80% (see, e.g. construct TM1/P2* in
Fig. 3A and construct *TM1–3(3R)/P29 in Fig. 5A), we conclude
that the N-tail is translocated into the lumen of the microsomes
in ;40% of the molecules and that the ProW C terminus is on
the cytoplasmic side of the membrane.
Topology of Truncated ProW Constructs—To map the topol-
ogy of ProW in more detail, we constructed fusions where the
reporter domains (the P2* and P29 domains and the C* tag)
were fused at various locations in ProW (Fig. 1).
The results for fusions to the P2* domain are summarized in
Fig. 3A (black bars). Unexpectedly, the P2* fusions after TM1
and TM3 were efficiently glycosylated, whereas the fusion after
TM2 was not glycosylated. On the other hand, and in agree-
ment with the topology determined in E. coli, the fusions after
TM4 and TM6 were more efficiently glycosylated than those
after TM5 and TM7. These observations suggest that the
TM1–3 part of ProW, when expressed without the downstream
TM segments, inserts with an inverted topology compared with
that adopted by the full-length molecules. In contrast, the
majority of the molecules in the longer ProW/P2* fusions have
the same C-terminal orientation as in E. coli.
To check whether the length of the C-terminal fusion domain
could affect the topology, fusions to the short C* tag were also
analyzed (Fig. 3A, white bars). In general, glycosylation levels
were lower in this case; this was expected, because glycosyla-
tion acceptor sites located close to the C terminus of a protein
are less efficiently modified than internal sites (29).3 The re-
sults for the C* fusions paralleled those of the P2* fusions,
except for construct TM1/C*, which was poorly glycosylated.
Possibly, because co-translational targeting may not be possi-
ble in this construct where the TM1 segment is still mostly
inside the ribosome at the time of chain termination, the pro-
3 I. Nilsson and G. von Heijne, unpublished data.
FIG. 1. Topology of ProW in E. coli (6, 18). The positions of all P2,
P29, and C* fusions and C-terminal truncations are indicated (when two
numbers are given, the first is for the P2 and P29 fusions). The position
of the three-Arg insertion (3R) in the TM1–2 loop and the number of
positively charged residues (Arg1Lys) in the different loops are also
shown.
FIG. 2. Localization of the N and C termini of full-length ProW
relative to the microsomal membrane. *ProW (lanes 1 and 2),
ProW/C* (lanes 3 and 4), and ProW/P2* (lanes 5 and 6) (asterisk indi-
cates the location of a unique glycosylation site in the relevant domain)
were expressed in vitro in the absence (2) and presence (1) of rough dog
pancreas microsomes (RM). Nonglycosylated and glycosylated forms
are indicated by white and black dots, respectively.
FIG. 3. Topology mapping of truncated ProW constructs. A,
degree of glycosylation of the P2* and C* C-terminal reporter domains
in ProW/P2* fusions (black bars) and ProW/C* fusions (white bars). B,
alkaline extraction of ProW/P2* fusions. Constructs were expressed in
vitro in the absence (2) and presence (1) of rough microsomes (RM),
and the microsomes were subjected to alkaline extraction (AE) before
loading onto the gel. Lanes 1–3, TM1–2/P2*; lanes 4–6, TM1–3/P2*.
Nonglycosylated and glycosylated forms are indicated by white and
black dots, respectively. C, degree of glycosylation of the N-tail in
*ProW/P29 fusions (black bars) and C-terminally truncated *ProW con-
structs (white bars).
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tein is only inefficiently targeted to the microsomes. In general,
however, the qualitative picture is the same for the ProW/P2*
and ProW/C* fusions, suggesting that the length of the C-
terminal reporter domain has little influence on the topology.
To rule out the possibility that lack of glycosylation was a
consequence of lack of membrane insertion of the protein, we
checked the membrane insertion of the TM1–2/P2* and TM1–
3/P2* constructs by carbonate extraction (30) (Fig. 3B). Both
constructs were quantitatively retained in the alkali-extracted
membrane pellet, demonstrating proper assembly into the mi-
crosomal membrane.
Because the C-terminal fusions suggested that the topology
may be different for proteins with up to three TM domains and
those with four or more, we also assayed N-tail translocation in
these constructs. To this end, we expressed *ProW/P29 fusions
and truncated *ProW molecules with a unique glycosylation
acceptor site in the N-tail (Fig. 3C). Little glycosylation of the
N-tail was seen for the *TM1/P29, *TM1–2/P29, and *TM1–3/
P29 constructs, whereas the *TM1–4/P29, *TM1–5/P29, *TM1–
6/P29, and *TM1–7/P29 constructs were glycosylated to between
20 and 30% (black bars). Similar results were seen with the
truncated ProW molecules (white bars), except that the
*TM1–4 construct was very inefficiently glycosylated. Thus,
N-tail translocation increases significantly when at least four
(P29 fusions) or five (truncated ProW molecules) TM segments
are present. The length of the C-terminal tail thus makes little
difference, except for the *TM1–4 constructs.
We conclude that only a very minor fraction of the ProW/P2
constructs with up to three TM segments is oriented with the
N-tail in the lumen, whereas a significant fraction (30–40%) of
those with four or more TM segments has a lumenal N-tail. The
efficiency of N-tail translocation in the TM1–4 constructs ap-
parently depends on the length of the C-terminal tail, with a
longer C-tail favoring a lumenal orientation of the N-tail.
Addition of Positively Charged Residues in the TM1-TM2
Loop Affects the Topology of the TM1–2/P2 and TM1–3/P2
Constructs—The TM1–2 loop lacks positively charged residues
(Fig. 1), which may contribute to the unexpected topology of the
shorter ProW constructs. To test this notion, three positively
charged arginine residues were inserted between positions 119
and 120 in the TM1-TM2 loop, and the topology of the resulting
TM1–2(3R) and TM1–3(3R) P2* and P29 fusions was probed by
the glycosylation status of unique N-terminal and C-terminal
acceptor sites (Fig. 4A). The N-tail was still poorly glycosylated
in both the *TM1–2(3R)/P29 and *TM1–3(3R)/P29 constructs. In
contrast, the P2-domain was more efficiently glycosylated in
the TM1–2(3R)/P2* construct than in the parent TM1–2/P2*
construct (34% versus 10%; cf. Fig. 3A), while the TM1–3(3R)/
P2* construct was much less efficiently glycosylated than its
parent (7% versus 60%). To rule out the possibility that the
position of the glycosylation site in the N-tail affected these
results, we introduced a second acceptor site in position 80, i.e.
20 residues upstream of TM1. The two resulting constructs,
**TM1–3/P29 and **TM1–3(3R)/P29, were as poorly glycosy-
lated as the parent constructs (data not shown). We also intro-
duced six consecutive arginines in the TM1-TM2 loop; again, no
N-tail translocation was seen for the resulting *TM1–3(6R)/P29
construct (data not shown). Thus, although the introduction of
positively charged residues in the TM1-TM2 loop leads to its
retention in the cytoplasm (and translocation of the TM2-TM3
loop to the lumen), it does not promote translocation of the
N-tail (Fig. 4B).
Shortening of the N-tail Increases Translocation Efficien-
cy—To study the effect of the length of the N-tail on its trans-
location, we deleted 24, 45, and 65 N-terminal amino acid
residues in the *TM1/P29, *TM1–2/P29, *TM1–3/P29, and
*TM1–3(3R)/P29 fusions (Fig. 5A). In all cases, a unique Asn3-
Ser4-Thr5 glycosylation site was present in the N-tail. Little
increase in N-tail glycosylation was seen for the shorter *TM1/
P29 and *TM1–2/P29 constructs. In contrast, shortening of the
N-tail in the *TM1–3/P29 construct led to an appreciable in-
crease in glycosylation efficiency. For the *TM1–3(3R)/P29 con-
struct, essentially complete N-tail translocation (i.e. ;80%
modification) was observed when the N-tail was shorter than
;50 residues.
N-tail translocation also became markedly more efficient in
the *TM1–3/P29, *TM1–4/P29, *TM1–5/P29, *TM1–6/P29, and
*TM1–7/P29 constructs when the N-tail was shortened to 30
residues (Fig. 5B; see also black bars in Fig. 3C), and similar
results were obtained with the corresponding C-terminally
truncated constructs (white bars; note that the *TM1(D1–70),
*TM1–2(D1–70), and *TM1–3(D1–70) truncations were too
poorly expressed to be analyzed).
Thus, N-tail translocation can be promoted by shortening the
N-tail, and can be further increased by the addition of posi-
tively charged residues to the TM1–2 loop. Again, for a given
length of the N-tail, we observe more efficient N-tail translo-
cation as the number of TM segments is increased. Interest-
ingly, the short N-tail in the *ProW(D1–70)/P29-constructs is
predominantly located in the lumen already when only three
TM domains are present, in contrast to the full-length N-tail
where four TM domains are required for significant transloca-
tion of the N-tail (Fig. 3C).
Efficient N-tail Translocation by Replacement of the ProW
TM Domain—Because the efficiency of N-tail translocation was
found to depend mainly on the number of transmembrane
segments, it was also of interest to check whether the identity
FIG. 4. Addition of three Arg residues to the TM1–2 loop en-
hances its retention in the cytoplasm. A, constructs *TM1–2(3R)/
P29 (lanes 1 and 2), TM1–2(3R)/P2* (lanes 3 and 4), *TM1–3(3R)/P29
(lanes 5 and 6), and TM1–3(3R)/P2* (lanes 7 and 8) were expressed in
vitro in the absence (2) and presence (1) of rough microsomes (RM).
Nonglycosylated and glycosylated forms are indicated by white and
black dots, respectively. B, topology models for the TM1–2(3R)/P2 (left)
and TM1–3(3R)/P2 (right) constructs. Solid Y-shaped symbol, glycosy-
lated site; outlined Y-shaped symbol, nonglycosylated site.
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of the transmembrane domain would affect the translocation
efficiency. We thus constructed fusions between the ProW N-
tail (residues 1–99) and Lep residues 1–215 (*Nt/Lep-P29) or
the full-length Lep protein (Nt/Lep-P2*). Lep has two trans-
membrane segments (residues 4–22 and 62–76), and both the
N and C terminus face the lumen when Lep is integrated into
microsomes (31, 32) (Fig. 6A). As shown in Fig. 6B, the ProW
N-tail was quite efficiently translocated in this context (59%
glycosylation of *Nt/Lep-P29), despite the fact that only two TM
segments are present, and the P2 domain was likewise trans-
located into the lumen as seen from the efficient glycosylation
(62%) of Nt/Lep-P2*.
Kinetics of N-tail Glycosylation in Nt/Lep-P29 Suggests That
the N-tail Is Translocated in a C-to-N-terminal Direction—The
rather efficient translocation of the full-length ProW N-tail in
the *Nt/Lep-P29 construct made it possible to study the direc-
tion of N-tail translocation. To this end, glycosylation acceptor
sites were introduced in position 5 or 80 near the N-terminal
and C-terminal ends of the N-tail, respectively (Fig. 6A). Syn-
chronized translation was initiated by the addition of mRNA to
the translation mix, and further chain initiation was blocked
after 1.5 min by addition of the inhibitor aurintricarboxylic
acid. The kinetics of glycosylation of the two sites was then
followed as initially described by Rothman and Lodish (33), i.e.
by dissolving the microsomes by addition of the detergent Tri-
ton X-100 at different time points (thus preventing further
glycosylation) and then allowing translation to go to comple-
tion. Results for the *Nt(Asn5)/Lep-P29 and *Nt(Asn80)/Lep-P29
constructs are shown in Fig. 7A. To rule out that the glycosy-
lated forms of the two constructs represent different popula-
tions of molecules, the analysis was carried out also for con-
struct **Nt(Asn5, Asn80)/Lep-P29 containing both sites.
As is clear from the quantitations in Fig. 7B, glycosylation of
the *Nt(Asn80)/Lep-P29 construct preceded that of the
*Nt(Asn5)/Lep-P29 construct by about 3 min. Glycosylation of
the Asn80 site was first detected about 7 min after initiation of
translation. Separate measurement of the overall translation
rate of the two constructs in the in vitro system yielded a value
of 0.4 amino acids/s (data not shown). Assuming a uniform
translation rate, the nascent chain is thus roughly 170 residues
long after 7 min. Because approximately 70 residues are re-
quired to span the distance between the ribosomal P-site and
the oligosaccharyl transferase active site (34), glycosylation of
Asn80 happens at about the time expected if translocation is
initiated by TM1, whereas Asn5 is glycosylated ;3 min later.
Glycosylation of the **Nt(Asn5, Asn80)/Lep-P29 construct pro-
ceeded in two steps separated by about 3 min, and the final
glycosylation levels were 53% doubly glycosylated molecules
and 14% singly glycosylated molecules (data not shown), con-
sistent with the results for the single acceptor site mutants.
These results strongly suggest that the N-tail is translocated
into the lumen in a C-to-N-terminal direction, starting with the
insertion of TM1 into the translocation apparatus. Interest-
ingly, the rate of N-tail translocation estimated from this ex-
periment is quite slow and roughly of the same order as the
rate of chain elongation.
FIG. 5. Shorter N-tails are more efficiently translocated. A,
degree of glycosylation of the N-tail in *TM1/P29 (black circles), *TM1–
2/P29 (white circles), *TM1–3/P29 (white squares), and *TM1–3(3R)/P29
(black squares) as a function of the number of residues in the N-tail. B,
degree of glycosylation of the N-tail in *ProW(D1–70)/P29 constructs
(black bars) and C-terminally truncated *ProW constructs (white bars).
FIG. 6. Efficient translocation of the ProW N-tail when fused to
the N terminus of Lep. A, the Nt/Lep fusion proteins (solid Y-shaped
symbol, glycosylated site). B, the *Nt/Lep-P29 (lane 1) and Nt/Lep-P2*
(lane 2) fusions were expressed in vitro in the presence of rough micro-
somes (RM). Nonglycosylated and glycosylated forms are indicated by
white and black dots, respectively.
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DISCUSSION
In this paper, we have analyzed the insertion of the E. coli
inner membrane protein ProW into ER-derived microsomal
membranes. In E. coli, the 100-residues long ProW N-tail is
efficiently translocated across the inner membrane in the
TM1–3/P2 construct, whereas in the shorter TM1/P2 construct
it is translocated in about 50% of the molecules (6). The lack of
positively charged residues immediately downstream of TM1
has been shown to be at least partly responsible for the appear-
ance of TM1/P2 molecules with an inverted Ncyt-Cexo topology
(7, 13).
The most unexpected finding in the present work is that very
little N-tail translocation across the microsomal membrane is
seen unless a minimum of four TM segments from ProW are
present (Fig. 8). Instead, an inverted topology with the N-tail
on the cytoplasmic side of the membrane dominates for the
TM1, TM1–2, and TM1–3 constructs as determined by the
glycosylation status of the N-tail and two different C-terminal
reporter domains. Only when a minimum of four TM segments
are present do we find a significant fraction of molecules with
the N-tail in the lumen. It thus appears that the whole TM1-
TM4 region has a direct influence on the translocation of the
N-tail. In general, the length of the C-terminal tail does not
influence N-tail translocation, except for the TM1–4 constructs
where the N-tail is more efficiently translocated in the *TM1–
4/P29 fusion than when the protein is truncated after TM4.
Because in the truncated *TM1–4 construct TM4 is still inside
the ribosome when chain termination happens, it may not be
able to influence the overall topology of the molecule in this
case.
Insertion of three positively charged residues in the TM1-
TM2 loop partially induces a topology with the TM1-TM2 loop
in the cytoplasm and the TM2-TM3 loop in the lumen but does
not lead to translocation of the N-tail unless it is shortened to
75 residues or less (Fig. 5A). Even without the extra positively
charged residues in the TM1–2 loop, shortening the N-tail to
;30 residues leads to efficient N-tail translocation for all con-
structs with three or more TM domains. Finally, when the
ProW N-tail is fused to another E. coli inner membrane protein
(Lep) with only two TM segments, it is quite efficiently
translocated.
Taken together, these results show that the balance between
the Ncyt and Nexo orientations of the N-tail can be affected by
sequence determinants more than 100 residues downstream of
the tail itself (i.e. TM4 in ProW). This suggests that the final
“decision” of whether or not to translocate the N-tail can be
influenced by the topological preferences of TM segments that
have not even been synthesized when TM1 enters the ER
translocon, because only ;40 residues are required to span the
distance between the translocon and the ribosomal P-site (35).
Two extreme models for how this could happen are that the
more N-terminal TM segments initially integrate into the ER
membrane with the N-tail in the cytoplasm and are then pulled
back into the translocon where they reorient as the more C-
terminal TMs appear or that the whole protein remains in an
“undecided” state inside the translocon until at least four TM
segments have been made. At present, we cannot say which of
the two models is closer to the truth, because experimental
data in favor of both have been reported in the literature (4,
36–40). It is of course also possible or even likely that different
proteins make the “topological decision” at different times dur-
ing their biosynthesis, as suggested by the rather efficient
FIG. 7. The ProW N-tail is translocated in a C-to-N-terminal
direction. The *Nt(Asn5)/Lep-P29 and *Nt(Asn80)/Lep-P29 constructs
were expressed in vitro in the presence of microsomes. After a 1.5-min
incubation, aurintricarboxylic acid was added to block further initia-
tion. Samples were removed at different time points, and Triton X-100
was added to dissolve the microsomes and block further glycosylation.
Translation was then allowed to continue up to a total time of 60 min.
A, selected time points of Triton X-100 addition for *Nt(Asn5)/Lep-P29
(top) and *Nt(Asn80)/Lep-P29 (bottom). Nonglycosylated and glycosy-
lated forms are indicated by white and black dots, respectively. B,
kinetics of glycosylation determined from two independent experiments
for each construct. White dots, *Nt(Asn5)/Lep-P29; black dots,
*Nt(Asn80)/Lep-P29). Mean values are shown by crosses.
FIG. 8. Topology models for the TM1/P2, TM1–2/P2, and TM1–
3/P2 fusions (top) and for full-length ProW (bottom) inserted into
microsomal membranes. Solid Y-shaped symbol, glycosylated site;
outlined Y-shaped symbol, nonglycosylated site. The number of posi-
tively charged residues (Arg1Lys) in the different loops are shown.
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N-tail translocation observed for the *Nt/Lep-P29 construct and
for the ProW constructs with shortened N-tails.
Finally, analysis of the glycosylation kinetics of two *Nt/Lep-
P29 constructs with glycosylation sites placed either N- or C-
terminally in the N-tail has allowed us to address a long stand-
ing question, namely whether N-tail translocation proceeds in
an N-to-C-terminal or C-to-N-terminal direction. The results
strongly suggest the latter and further imply that the rate of
N-tail translocation is of the same order as the rate of chain
elongation, at least in our in vitro system.
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